New research fails to support efficacy of desvenlafaxine for treating MDD in adolescents

(Mary Ann Liebert, Inc./Genetic Engineering News) New studies in children and adolescents with major depressive disorder (MDD) reported negative outcomes, failing to support the effectiveness of desvenlafaxine (Pristiq, Pfizer) compared to placebo.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2EXUhXY